S H Swerdlow
Overview
Explore the profile of S H Swerdlow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goodlad J, Cerroni L, Swerdlow S
Virchows Arch
. 2022 Oct;
482(1):281-298.
PMID: 36278991
The Revised European-American Classification of mature lymphoid neoplasms published in 1994 and the 2001, 2008 and 2016 WHO classifications that followed, were the product of international collaboration and consensus amongst...
2.
Aggarwal N, Swerdlow S, TenEyck S, Boyiadzis M, Felgar R
Cytometry B Clin Cytom
. 2015 Dec;
90(4):349-57.
PMID: 26648320
The impact of the immune microenvironment on the behavior and therapeutic strategies for hematopoietic and lymphoid neoplasms is being increasingly recognized. Many functional studies of natural killer (NK) cell cytotoxic...
3.
Swerdlow S, Murray L, Habeshaw J
Immunol Today
. 2014 Oct;
6(7):200.
PMID: 25290176
No abstract available.
4.
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease
Royo C, Navarro A, Clot G, Salaverria I, Gine E, Jares P, et al.
Leukemia
. 2012 Mar;
26(8):1895-8.
PMID: 22425896
No abstract available.
5.
Jacobs S, Harrison A, Swerdlow S, Foon K, Avril N, Vidnovic N, et al.
Mol Imaging Biol
. 2008 Sep;
11(1):39-45.
PMID: 18773247
Purpose: (90)Yttrium-ibritumomab-tiuxetan (Zevalin) is an effective treatment for relapsed or refractory low-grade, follicular, or transformed B-cell NHL. The purpose of this study is to assess whether tissue and cellular localization...
6.
Campo E, Chott A, Kinney M, Leoncini L, Meijer C, Papadimitriou C, et al.
Histopathology
. 2006 Apr;
48(5):481-504.
PMID: 16623775
Classification and proper treatment of extranodal lymphoma is hindered by the diversity of lymphoma types and the relative rarity of many of these tumour types. In order to review controversial...
7.
Ohori N, Whisnant R, Nalesnik M, Swerdlow S
Diagn Cytopathol
. 2001 Jul;
25(1):50-3.
PMID: 11466813
Pleural effusion presentation of posttransplant lymphoproliferative disorder (PTLD) is relatively uncommon. Most examples of effusion-based PTLD have been secondary to widespread solid organ involvement, and are associated with an aggressive...
8.
Andriko J, Swerdlow S, Aguilera N, Abbondanzo S
Am J Surg Pathol
. 2001 Jun;
25(6):742-51.
PMID: 11395551
Lymphoplasmacytic lymphoma/immunocytoma (LLI) was defined initially as a small B-cell lymphoma with plasmacytoid or plasmacytic features. Because other types of small B-cell lymphoma, particularly marginal zone B-cell lymphoma may exhibit...
9.
Przybylski G, Wu H, Macon W, Finan J, Leonard D, Felgar R, et al.
J Mol Diagn
. 2001 Mar;
2(1):11-9.
PMID: 11272897
Gamma/delta T cell lymphomas (gamma/delta TCL) represent rare, often aggressive types of T cell malignancy that are clinically and pathologically diverse. Most gamma/delta TCL occur as a hepatosplenic or subcutaneous...
10.
King B, Chen C, Locker J, Kant J, Okuyama K, Falini B, et al.
Mod Pathol
. 2000 Dec;
13(11):1219-31.
PMID: 11106080
Diffuse large B-cell lymphomas (DLBCL) are a biologically and clinically heterogeneous entity. Although some DLBCL represent transformation of follicular lymphomas (FL), the proportion that is of follicular center cell (FCC)...